The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.
Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue ...
Illumina (ILMN) is reducing its forecast for this year’s financial performance and cutting $100M in spending because China barred sales of its ...
The company added that the cost savings would mitigate the impact of a potential reduction in revenue and related operating ...
China banned the import of Illumina Inc. gene-sequencing machines as part of a wave of retaliatory trade measures in response ...
Illumina has been barred from exporting its DNA sequencers to China, which closed | Illumina has been barred from exporting ...
Illumina is not banned from operating in the country and will continue to serve its existing customers, a company ...
Today, Benzinga's options scanner identified 8 options transactions for Illumina. This is an unusual occurrence. The ...
Canaccord lowered the firm’s price target on Illumina (ILMN) to $115 from $135 and keeps a Hold rating on the shares. The firm’s target ...
The import ban on Illumina's NGS sequencers follows its placement on China's Ministry of Commerce's (MOFCOM) ‘Unreliable Entity List’ last month. Image credit: JHVEPhoto via Shutterstock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback